New study aims to spot which pancreatic cysts could turn cancerous
NCT ID NCT02110498
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 3,000 adults with pancreatic cysts to find better ways to tell harmless cysts from those that might become cancer. Researchers used imaging scans, cyst fluid analysis, and genetic markers to improve accuracy. The goal is to help doctors make better decisions about treatment and monitoring.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this research could lead to more accurate tests to identify which pancreatic cysts are dangerous, helping patients avoid unnecessary surgery or catch cancer early.
- What could go wrong
- This is an observational study, not a treatment trial. The findings may not lead to immediate changes in patient care, and the tests studied might not prove reliable enough for widespread use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 3,000 people
The number the study aims to enrol. It can still change while the study runs.
- Start date
-
Mar 2014
- Finished
-
Mar 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Any individual with a pancreatic cyst seen at the Johns Hopkins Hospital or other participating Institutions.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adult patients age 18 years and older with pancreatic cyst. Exclusion Criteria: * Individuals with ASA class 4 or greater. * Inability to provide informed consent. * Pregnancy or lactation.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cystic, mucinous and/or serous neoplasm are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Johns Hopkins Hospital
Baltimore, Maryland, 21231, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pancreatic Cancer's inflammatory footprint be stopped?
- Could a simple blood test catch pancreatic cancer before It's too late?
- Zapping pancreatic tumors without surgery: a safer approach?
- Could a breast cancer drug stop pancreatic cysts from becoming cancer?
- New pancreatic cancer registry aims to unlock disease secrets
- Massive pancreatic surgery registry launches to improve patient care